Cargando…

Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy?

Background Neodymium-doped yttrium aluminium garnet (Nd:YAG) posterior capsulotomy is a common treatment for posterior capsular opacification. Practice varies regarding routine follow-up. In this study, we reviewed follow-up rates and treatment-related complications from a district general hospital’...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson-May, James G, La, Chuiki J, Chihaia, Madalina A, Clarke, Holly, Light, Michelle, Rashid, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893007/
https://www.ncbi.nlm.nih.gov/pubmed/35261829
http://dx.doi.org/10.7759/cureus.21803
_version_ 1784662291964231680
author Richardson-May, James G
La, Chuiki J
Chihaia, Madalina A
Clarke, Holly
Light, Michelle
Rashid, Mohammed
author_facet Richardson-May, James G
La, Chuiki J
Chihaia, Madalina A
Clarke, Holly
Light, Michelle
Rashid, Mohammed
author_sort Richardson-May, James G
collection PubMed
description Background Neodymium-doped yttrium aluminium garnet (Nd:YAG) posterior capsulotomy is a common treatment for posterior capsular opacification. Practice varies regarding routine follow-up. In this study, we reviewed follow-up rates and treatment-related complications from a district general hospital’s ophthalmology unit to assess areas for improvement and cost-effectiveness. Methodology We conducted a retrospective review of electronic patient records for all patients treated with Nd:YAG capsulotomy in 2019 at our hospital. Primary outcomes included visual acuity, complications, and follow-up data. Secondary outcomes included medication prescribing and the grade of surgeon. Results In total, 912 eyes of 744 patients were included. Overall, 536 (58.8%) eyes were discharged immediately following their laser. Complication rate was 4.3% (39 eyes). Junior training grades had a higher rate of medication prescribing (40/46 eyes; 87.0%) and follow-up (36/40 eyes; 78.3%). Conclusions Certain selected patients may be safely discharged following capsulotomy with safety-netting advice. This strategy increases the capacity to follow-up patients at higher risk of complications. Higher rates of follow-up among junior ophthalmologists offers potential for training.
format Online
Article
Text
id pubmed-8893007
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-88930072022-03-07 Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy? Richardson-May, James G La, Chuiki J Chihaia, Madalina A Clarke, Holly Light, Michelle Rashid, Mohammed Cureus Ophthalmology Background Neodymium-doped yttrium aluminium garnet (Nd:YAG) posterior capsulotomy is a common treatment for posterior capsular opacification. Practice varies regarding routine follow-up. In this study, we reviewed follow-up rates and treatment-related complications from a district general hospital’s ophthalmology unit to assess areas for improvement and cost-effectiveness. Methodology We conducted a retrospective review of electronic patient records for all patients treated with Nd:YAG capsulotomy in 2019 at our hospital. Primary outcomes included visual acuity, complications, and follow-up data. Secondary outcomes included medication prescribing and the grade of surgeon. Results In total, 912 eyes of 744 patients were included. Overall, 536 (58.8%) eyes were discharged immediately following their laser. Complication rate was 4.3% (39 eyes). Junior training grades had a higher rate of medication prescribing (40/46 eyes; 87.0%) and follow-up (36/40 eyes; 78.3%). Conclusions Certain selected patients may be safely discharged following capsulotomy with safety-netting advice. This strategy increases the capacity to follow-up patients at higher risk of complications. Higher rates of follow-up among junior ophthalmologists offers potential for training. Cureus 2022-02-01 /pmc/articles/PMC8893007/ /pubmed/35261829 http://dx.doi.org/10.7759/cureus.21803 Text en Copyright © 2022, Richardson-May et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Ophthalmology
Richardson-May, James G
La, Chuiki J
Chihaia, Madalina A
Clarke, Holly
Light, Michelle
Rashid, Mohammed
Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy?
title Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy?
title_full Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy?
title_fullStr Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy?
title_full_unstemmed Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy?
title_short Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy?
title_sort can routine patients be safely discharged after neodymium-doped yttrium aluminium garnet laser posterior capsulotomy?
topic Ophthalmology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893007/
https://www.ncbi.nlm.nih.gov/pubmed/35261829
http://dx.doi.org/10.7759/cureus.21803
work_keys_str_mv AT richardsonmayjamesg canroutinepatientsbesafelydischargedafterneodymiumdopedyttriumaluminiumgarnetlaserposteriorcapsulotomy
AT lachuikij canroutinepatientsbesafelydischargedafterneodymiumdopedyttriumaluminiumgarnetlaserposteriorcapsulotomy
AT chihaiamadalinaa canroutinepatientsbesafelydischargedafterneodymiumdopedyttriumaluminiumgarnetlaserposteriorcapsulotomy
AT clarkeholly canroutinepatientsbesafelydischargedafterneodymiumdopedyttriumaluminiumgarnetlaserposteriorcapsulotomy
AT lightmichelle canroutinepatientsbesafelydischargedafterneodymiumdopedyttriumaluminiumgarnetlaserposteriorcapsulotomy
AT rashidmohammed canroutinepatientsbesafelydischargedafterneodymiumdopedyttriumaluminiumgarnetlaserposteriorcapsulotomy